Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Alert
Watchlist
Jenburkt Pharmaceuticals
₹1,152.10
+0.40 (0.03%) 1D
Create Stock SIPAutomate your investments in this
Performance
Open
1,151.70Prev. Close
1,151.70Volume
1,832Total traded value
0.21 CrUpper Circuit
1,382.00Lower Circuit
921.40Fundamentals
| Market Cap | ₹508Cr |
| ROE | 18.04% |
| P/E Ratio(TTM) | 15.40 |
| EPS(TTM) | 74.77 |
| P/B Ratio | 2.78 |
| Dividend Yield | 1.56% |
| Industry P/E | 41.00 |
| Book Value | 414.39 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Jenburkt Pharma
Jenburkt is a pharmaceutical company that has established itself as a leader in pain management and primary care in India, with over four decades of experience. The company is guided by a core philosophy of prioritizing patients, aiming to transform lives one patient, one family, and one community at a time. Today, its leading brand Nervijen ranks as number 6 in the Vitamin, Mineral and Nutrients category within the highly competitive Indian market.;
| Parent Organisation | Jenburkt Pharmaceuticals Limited |
| Managing Director | Shri. Ashish Bhuta |
| BSE Symbol | 524731 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.85 | ||
| Gland Pharma | NA (0.00%) | 40.72 | ||
| Ajanta Pharma | NA (0.00%) | 33.06 | ||
| Eris Lifesciences | NA (0.00%) | 53.97 |